Study of Nivolumab + Ipilimumab Versus Nivolumab Alone – lay summary

While attending the 2015 European Cancer Congress (ECC) and the European Society for Medical Oncology (ESMO), Deb Maskens (Kidney Cancer Canada) participated in an interview with Bettina Ryll, MD, PhD, chair of the ESMO Patient Advocacy Working Group and a founding member of the Melanoma Patient Network Europe. Deb and Dr. Ryll discussed the role […]

by Juanita Ruiz, Colombia Throughout the first semester of 2016 Fundación SIMMON has held three cancer patients’ meetings part of its “ASSIST” program. The program’s objective is to contribute to a better quality of life for cancer patients, relatives and caregivers by providing education and leisure opportunities in meetings where they can ask their questions […]

After years of advocacy emphasizing the lack of kidney cancer federal funding, on Tuesday, May 17th, the House Appropriations Committee approved the FY17 Defense Appropriations Act and forwarded the bill to the full House.  The fiscal year 2017 Defense appropriations bill includes a $10 million line item within the Defense Health Program, Congressional Directed Medical […]